financetom
Business
financetom
/
Business
/
Nukkleus Prices $10 Million Private Placement; Shares Drop Pre-Bell
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nukkleus Prices $10 Million Private Placement; Shares Drop Pre-Bell
Dec 19, 2024 3:32 AM

06:06 AM EST, 12/19/2024 (MT Newswires) -- Nukkleus ( NUKK ) said late Wednesday it priced a private placement of 1.7 million units at $6 per unit for gross proceeds of $10 million.

Each unit consists of one share of restricted common stock and warrants exercisable for one and one-half of shares of restricted common stock at $6 per share.

The company said the placement is with a single New York-based family office investor.

Net proceeds from the offering, which is expected to close around Thursday, will be used to finance the proposed acquisition of Star 26 Capital, a defense acquisition company holding 95% ownership in RIMON, as well as for general corporate purposes and working capital.

Shares of the company fell more than 16% in premarket activity Thursday.

Price: 42.49, Change: -8.30, Percent Change: -16.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
XOMA Royalty Acquires Royalty Interest in Twist Bioscience's Biopharma Programs
XOMA Royalty Acquires Royalty Interest in Twist Bioscience's Biopharma Programs
Oct 22, 2024
08:58 AM EDT, 10/22/2024 (MT Newswires) -- XOMA Royalty ( XOMA ) said Tuesday it has acquired a 50% economic interest in all future milestones and royalties associated with more than 60 early-stage programs under Twist Bioscience's ( TWST ) biopharma business for an upfront payment of $15 million. The deal brings XOMA's portfolio to over 100 assets ranging from...
GATX's Q3 Non-GAAP Earnings, Revenue Climb; 2024 Earnings Guidance Updated
GATX's Q3 Non-GAAP Earnings, Revenue Climb; 2024 Earnings Guidance Updated
Oct 22, 2024
08:59 AM EDT, 10/22/2024 (MT Newswires) -- GATX ( GATX ) reported Q3 non-GAAP earnings Tuesday of $2.50 per diluted share, up from $1.44 a year earlier. Two analysts polled by Capital IQ expected $1.96. Revenue for the quarter ended Sept. 30 was $405.4 million, compared with $360.1 million a year earlier. Two analysts surveyed by Capital IQ expected $391.7...
Starboard says Kenvue's skin health segment is weighing on performance
Starboard says Kenvue's skin health segment is weighing on performance
Oct 22, 2024
NEW YORK, Oct 22 (Reuters) - Starboard Value called consumer products company Kenvue ( KVUE ) a bargain and said its skin health and beauty segment's lackluster growth is the reason for the stock's underperformance. Starboard Chief Investment Officer Jeffrey Smith said there is an opportunity to improve revenue growth and margins at the segment which has the Neutrogena and...
Update: Market Chatter: Carlyle Group Bows Out of Bidding Process for Thyssenkrupp Warship Unit
Update: Market Chatter: Carlyle Group Bows Out of Bidding Process for Thyssenkrupp Warship Unit
Oct 22, 2024
08:59 AM EDT, 10/22/2024 (MT Newswires) -- (Update with Thyssenkrupp's response in the second paragraph.) Carlyle Group ( CG ) has withdrawn from the bidding process for the warship division of Thyssenkrupp, Reuters reported Tuesday, citing an email from the German industrial engineering and steel production company. We can confirm that the private equity firm Carlyle Group ( CG )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved